Search - tctmd.com

Displaying 541 - 560 of 638

Sort: Relevancy | Date

News Conference News TCT 2014

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

September 14, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

Presentation TCT 2014

Valvular Heart Disease for the Interventionalist

Presenter: Greg L. Kaluza, Manish A. Parikh, Varinder P. Singh, Nicola Corvaja

September 12, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Industry News

Access to Abbott's MitraClip® System Expands in the U.S. with Medicare National Coverage Determination

August 12, 2014

News Industry News

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

July 23, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

News Industry News

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

May 21, 2014

News Industry News

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

May 07, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

News Industry News

Abbott's First-of-Its-Kind MitraClip® Device Now Approved in Canada

April 30, 2014

Presentation ECHO 2014

Right Heart Valvular Disease: When to Intervene

Presenter: Linda D. Gillam

April 09, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

March 24, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Las Nuevas Directrices sobre el Manejo de la Cardiopatía Valvular Integran Intervenciones basadas en Catéteres

L.A. McKeown

March 20, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

Presentation TCT 2013

Valvular Heart Disease: Best of EHJ

Presenter: Stephan Windecker

October 30, 2013

Advertisement

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Valvular Heart Disease for the Interventionalist

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Access to Abbott's MitraClip® System Expands in the U.S. with Medicare National Coverage Determination

Efficacy and Safety Profile of Pradaxa® (dabigatran etexilate) Repeatedly Confirmed

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

New study to investigate dabigatran etexilate for prevention of recurrent stroke in high-risk patients

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Abbott's First-of-Its-Kind MitraClip® Device Now Approved in Canada

Right Heart Valvular Disease: When to Intervene

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Las Nuevas Directrices sobre el Manejo de la Cardiopatía Valvular Integran Intervenciones basadas en Catéteres

Survival After Septal Ablation for HOCM Similar to General Population

Valvular Heart Disease: Best of EHJ

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content